RecruitingPhase 4NCT06908252
MAPS PrEP Van Study
Integrating PrEP Into Mobile Addiction Treatment and Primary Care Services
Sponsor
Duke University
Enrollment
20 participants
Start Date
Sep 17, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program
Exclusion Criteria1
- positive HIV status
Interventions
DRUGPre-Exposure Prophylaxis (PrEP)
Oral Pre-Exposure Prophylaxis (PrEP) pills
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06908252
Related Trials
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
NCT0492902814 locations
#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
NCT0690082928 locations
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
NCT070429452 locations
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
NCT050775275 locations
Multiplo Tp/HIV Self-Test
NCT067164503 locations